Merck & Co., Inc: all 2,453 studies
Page 21 of 25. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.
- The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment PeriodCompletedNCT00892970Phase 2
- BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)CompletedNCT00887601Phase 1
- Exploratory Pharmacokinetic and Bioavailability Study of 2 Capsule Formulations of Torezolid PhosphateCompletedNCT00876655Phase 1
- Dose Escalation Study of ARQ 197 in Combination With Gemcitabine in Adult Patients With Advanced Solid TumorsCompletedNCT00874042Phase 1
- Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630)CompletedNCT00871910Phase 1
- Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6)CompletedNCT00871663Phase 1
- SCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715)TerminatedNCT00871546Phase 2
- Study of Biomarkers of Airway Inflammation (0000-128)CompletedNCT00869596Phase 1
- A Single-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) in Healthy VolunteersCompletedNCT00863590Phase 1
- A Study to Assess the Effects of a Light Breakfast on the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822)CompletedNCT00863525Phase 1
- A Comparison of Measurements of Ketone Body Flux Versus Ketone Body Concentration as a Pharmacodynamic Marker of Hepatic Fatty Acid Oxidation (0000-110)CompletedNCT00860392Phase 1
- The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males (MK-0000-127)CompletedNCT00856960Phase 1
- A Study of a Bivalent Influenza Peptide Conjugate Vaccine in Healthy AdultsCompletedNCT00851266Phase 1
- Three-Dose Regimen of MRKAd5+6 Trigene (V526) in Healthy Adults (V526-001)(COMPLETED)CompletedNCT00850616Phase 1
- A Worldwide, Phase I, Dose-Escalating Study of a 3-Dose Regimen of the MRKAd5 (Clade B) Vaccine in Healthy Adults (V520-018)CompletedNCT00849732Phase 1
- Study 08-114 Open-label Extension of Study 08-110 - A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease (P08642)TerminatedNCT00846781Phase 3
- Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)CompletedNCT00844922Phase 2
- A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)WithdrawnNCT00837941Phase 2
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)CompletedNCT00831662Phase 3
- Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)CompletedNCT00831545Phase 2
- Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123)CompletedNCT00828269Phase 1
- Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid TumorsCompletedNCT00827177Phase 1
- Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic MalignanciesCompletedNCT00825487Phase 1
- A Study of Ridaforolimus in Non-Small Cell Lung Cancer (NSCLC) Patients With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations (MK-8669-021 AM1)TerminatedNCT00818675Phase 2
- A Study to Evaluate the Effect of Testosterone on Muscle Fractional Synthetic Rate (MK-0000-064)CompletedNCT00816712Phase 1
- Biomarkers of Muscle Anabolism (MK-0000-082)CompletedNCT00812396Phase 1
- Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED)TerminatedNCT00811967Phase 3
- Assessment of the Effectiveness of OLMETEC® and OLMETEC PLUS® for Treatment of Hypertension in Stage I and II Patients (Study P05254)(COMPLETED)CompletedNCT00811226
- A Clinical Study to Determine Biomarkers of Response to a Gamma Secretase InhibitorCompletedNCT00803894Phase 1
- Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)CompletedNCT00802555Phase 1
- A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED)CompletedNCT00798395Phase 1
- SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717AM2)(TERMINATED)TerminatedNCT00798213Phase 2
- A Pharmacokinetics/Pharmacodynamics Study of SCH 900518 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C (Protocol No. P05104AM2)(COMPLETED)CompletedNCT00797745Phase 2
- Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732)TerminatedNCT00796250Phase 3
- Efficacy of Remicade in the Treatment of Active Rheumatoid Arthritis Despite Methotrexate (Study P03027)CompletedNCT00794898Phase 4
- Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)CompletedNCT00787371Phase 2
- MK0524 Asthma POC Study (0524-008)(COMPLETED)CompletedNCT00783601Phase 2
- SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma (Study P03745)CompletedNCT00783393Phase 2
- A Comparison of Analgesic Efficacy Between a Single Dose of ORG 28611, Morphine, and Placebo After Dental Impaction Surgery (Study P05800)TerminatedNCT00782951Phase 2
- Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED)CompletedNCT00781846Phase 1
- A Follow up Safety Study of Patients Who Participated in Previous Studies of the Drug Org 24448 (Study P05719)(COMPLETED)CompletedNCT00780585
- A Study to Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Chemotherapy (P03625)CompletedNCT00780039Phase 2
- Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED)CompletedNCT00779935Phase 4
- A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948)CompletedNCT00779129Phase 2
- A Study of the Efficacy and Tolerance of Remicade in the Treatment of Active Ankylosing Spondylitis (Study P04042)(COMPLETED)CompletedNCT00779012Phase 4
- Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002)CompletedNCT00777959Phase 2
- A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00777309Phase 2
- A Study to Test Once-Weekly Doses of Odanacatib (MK0822) on Healthy Adult Females (0822-005)(COMPLETED)CompletedNCT00770159Phase 1
- Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002)CompletedNCT00769418Phase 1
- MK0633 Single Dose Study in Japanese Asthmatic Children Aged 12 to Less Than 16 Years (0633-028)CompletedNCT00768170Phase 1
- A Placebo-Controlled Study of INS117548 Ophthalmic Solution in Subjects With Glaucoma (P08650)CompletedNCT00767793Phase 1
- Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED)CompletedNCT00762983
- A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)CompletedNCT00757939Phase 1
- A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 (ActRIIB-IgG1)in Healthy Postmenopausal VolunteersCompletedNCT00755638Phase 1
- Ezetrol Post-Marketing StudyCompletedNCT00753883Phase 4
- Plasma Levels of MK0633 in Children Ages 6-12 (0633-023)CompletedNCT00751413Phase 1
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK0683 in Patients With Advanced Cancer (0683-008)CompletedNCT00750178Phase 1
- The Canadian Follow-up Program for the ATTRACT Study (P04868)(TERMINATED)TerminatedNCT00748930
- Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6)CompletedNCT00739830Phase 2
- Oral Deforolimus With Trastuzumab for Patients With HER2-positive Trastuzumab-Refractory Metastatic Breast Cancer (8669-009)CompletedNCT00736970Phase 2
- Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034)WithdrawnNCT00733122Phase 3
- SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716)CompletedNCT00732810Phase 2
- Single-Dose Escalation Study of IDX184 in Healthy Volunteers (MK-2355-002)CompletedNCT00730431Phase 1
- A Combination Study With Ridaforolimus (MK8669) and Dalotuzumab (MK0646) in Patients With Advanced Cancer (8669-004)CompletedNCT00730379Phase 1
- Phase I Imaging Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (MK-0646-008)CompletedNCT00729742Phase 1
- Hemodynamic Effects of Rolofylline in the Treatment of Patients With Heart Failure (7418-503)CompletedNCT00729222Phase 2
- Post-marketing Surveillance of Children With Chronic Hepatitis C Treated With Intron A (Vial or Pen) and Rebetol (Study P04397)(TERMINATED)TerminatedNCT00727077
- Diagnostic Criteria in the Diagnosis of Spinal Spondyloarthropathies in Patients With Chronic Low Back Pain (Study P05320)(COMPLETED)CompletedNCT00726765
- A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)WithdrawnNCT00724672
- PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1 (Study P04511)(COMPLETED)CompletedNCT00724620Phase 4
- Safety and Efficacy of PegIntron and Rebetol Combination Therapy in Patients With Chronic Hepatitis C in Japan (Study P04505)CompletedNCT00724295
- Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED)CompletedNCT00724230
- Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206)TerminatedNCT00723879
- A Study to Test the Tolerability of an Investigational Electroporation Device in Healthy Adults (V930-001)CompletedNCT00721461Phase 1
- A Safety, Tolerability and Pharmacodynamics Study of ACE-011 (ActRIIA-IgG1) in Healthy Postmenopausal WomenCompletedNCT00709540Phase 1
- Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED)TerminatedNCT00705471
- Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)CompletedNCT00705419
- Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062)CompletedNCT00705198
- Evaluation of Treatment and Prophylaxis of Invasive Fungal Infections in Immuncompromised Patients in Austria (Study P05532)(WITHDRAWN)WithdrawnNCT00704951
- An Observational Study of Patients With Chronic Hepatitis C Undergoing Treatment With PegIntron and Rebetol in Clinical Practice in Belgium (Study P05494)(WITHDRAWN)WithdrawnNCT00704756
- A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors (8669-028)(COMPLETED)CompletedNCT00704054Phase 1
- A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019)CompletedNCT00703833Phase 2
- MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)TerminatedNCT00703690Phase 2
- A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)CompletedNCT00696826Phase 1
- Study of Ridaforolimus (MK-8669) in Participants With Solid Tumors (MK-8669-003)(COMPLETED)CompletedNCT00694083Phase 1
- A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001)TerminatedNCT00692614Phase 2
- A Study to Assess the Effects of MK0822 in Reducing the Risk of Bone Metastasis in Women With Breast Cancer (0822-029)WithdrawnNCT00692458Phase 3
- A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030)WithdrawnNCT00691899Phase 3
- Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)CompletedNCT00687011Phase 4
- Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)Approved for marketingNCT00686621
- Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019)CompletedNCT00685776Phase 3
- Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)CompletedNCT00684463Phase 4
- A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic SolutionCompletedNCT00680108Phase 2
- PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive InfectionsCompletedNCT00679835Phase 1
- A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye DiseaseCompletedNCT00679718Phase 2
- Study of the Effect of SCH 900538 on Congestion in Subjects With Seasonal Allergic Rhinitis (Study P05031)(COMPLETED)CompletedNCT00673062Phase 2
- Single and Multiple Ascending Dose Pharmacokinetic Study of TR701 in Healthy AdultsCompletedNCT00671814Phase 1
- Food Effects of Single Oral Dose of 600mg TR-701CompletedNCT00671359Phase 1
- Microdialysis and Pharmacokinetic Study of TR-701CompletedNCT00666601Phase 1
- Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)WithdrawnNCT00664287Phase 3